Cargando…

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes

AIM: Data on the safety of moderately hypofractionated proton beam therapy (PBT) are limited. The aim of this study is to compare the acute toxicity and early quality of life (QoL) outcomes of normofractionated (nPBT) and hypofractionated PBT (hPBT). MATERIAL AND METHODS: We prospectively compared a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pelak, Maciej J., Flechl, Birgit, Hug, Eugen, Galalae, Razvan, Konrath, Lisa, Góra, Joanna, Fossati, Piero, Lütgendorf-Caucig, Carola, Tubin, Slavisa, Konstantinovic, Rastko, Mock, Ulrike, Fussl, Christoph, Georg, Petra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425455/ https://www.ncbi.nlm.nih.gov/pubmed/36052240 http://dx.doi.org/10.3389/fonc.2022.962697

Ejemplares similares

The Value of SSTR2 Receptor-Targeted PET/CT in Proton Irradiation of Grade I Meningioma
por: Pelak, Maciej J., et al.
Publicado: (2021)

Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience
por: Tubin, Slavisa, et al.
Publicado: (2023)

Novel Carbon Ion and Proton Partial Irradiation of Recurrent Unresectable Bulky Tumors (Particle-PATHY): Early Indication of Effectiveness and Safety
por: Tubin, Slavisa, et al.
Publicado: (2022)

Evaluation of the inter- and intrafraction displacement for head patients treated at the particle therapy centre MedAustron based on the comparison of different commercial immobilisation devices
por: Zechner, Andrea, et al.
Publicado: (2021)

Effectiveness of hypofractionated and normofractionated radiotherapy in a triple‐negative breast cancer model
por: Grosche, Sinja, et al.
Publicado: (2022)

A Review of Particle Therapy for Skull Base Tumors: Modern Considerations and Future Directions
por: Hug, Eugen B., et al.
Publicado: (2021)

A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer
por: Borm, Kai J., et al.
Publicado: (2021)

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer
por: Nakajima, Koichiro, et al.
Publicado: (2022)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Alfredo, Conti, et al.
Publicado: (2019)

Correction to: Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Conti, Alfredo, et al.
Publicado: (2020)

Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY)
por: Tubin, Slavisa, et al.
Publicado: (2020)

Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis
por: Issoufaly, Irfane, et al.
Publicado: (2022)

Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment
por: Lütgendorf-Caucig, Carola, et al.
Publicado: (2020)

Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3)
por: Sarria, Gustavo R., et al.
Publicado: (2022)

Planning Strategy to Optimize the Dose-Averaged LET Distribution in Large Pelvic Sarcomas/Chordomas Treated with Carbon-Ion Radiotherapy
por: Nachankar, Ankita, et al.
Publicado: (2023)

An MRI sequence independent convolutional neural network for synthetic head CT generation in proton therapy
por: Zimmermann, Lukas, et al.
Publicado: (2021)

A Definitive IMRT-SIB with Concomitant Chemotherapy for Synchronous Locally Advanced Anal Canal Cancer and Prostate Cancer
por: Slavisa, Tubin, et al.
Publicado: (2018)

Carbon Ion Dose Constraints in the Head and Neck and Skull Base: Review of MedAustron Institutional Protocols
por: Fossati, Piero, et al.
Publicado: (2021)

Performance validation of deformable image registration in the pelvic region
por: Zambrano, V., et al.
Publicado: (2013)

Vienna Summer School on Oncology: how to teach clinical decision making in a multidisciplinary environment
por: Lütgendorf-Caucig, Carola, et al.
Publicado: (2017)

Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines
por: Schatz, Julia, et al.
Publicado: (2022)

Time-synchronized immune-guided SBRT partial bulky tumor irradiation targeting hypoxic segment while sparing the peritumoral immune microenvironment
por: Tubin, Slavisa, et al.
Publicado: (2019)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
por: Klement, Rainer J., et al.
Publicado: (2021)

MMAP-08 CHEMO-REIRRADIATION (NORMOFRACTIONATED VS. HYPOFRACTIONATED) WITH OR WITHOUT BEVACIZUMAB IN RECURRENT ADULT DIFFUSE HIGH-GRADE GLIOMA (COBRA): PHASE III RANDOMIZED CONTROLLED TRIAL WITH A 2 X 2 FACTORIAL DESIGN
por: Baviskar, Yamini, et al.
Publicado: (2022)

Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects
por: Tubin, Slavisa, et al.
Publicado: (2019)

Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment
por: Tubin, Slavisa, et al.
Publicado: (2021)

Impact of SSTR PET on Inter-Observer Variability of Target Delineation of Meningioma and the Possibility of Using Threshold-Based Segmentations in Radiation Oncology
por: Kriwanek, Florian, et al.
Publicado: (2022)

A quantitative comparison of the performance of three deformable registration algorithms in radiotherapy
por: Fabri, Daniella, et al.
Publicado: (2013)

Unique Finding of a Primary Central Nervous System Neuroendocrine Carcinoma in a 5-Year-Old Child: A Case Report
por: Stepien, Natalia, et al.
Publicado: (2022)

Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio
por: Lu, Qiuxia, et al.
Publicado: (2023)

Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment
por: Tubin, Slavisa, et al.
Publicado: (2019)

The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma
por: Wang, Li, et al.
Publicado: (2021)

Is standard breast-conserving therapy (BCT) in elderly breast cancer patients justified? A prospective measurement of acute toxicity according CTC-classification
por: Galalae, Razvan M, et al.
Publicado: (2010)

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020)

Hypofractionation: less is more?
por: Mariam, Neethu Billy Graham, et al.
Publicado: (2021)

Salvage high-dose-rate brachytherapy for prostate cancer persistence after brachytherapy: repeated use of a polyethylene glycol hydrogel spacer
por: Hepp, Rodrigo, et al.
Publicado: (2018)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2t6msv0p2bipaenchtt3mv193p